Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials / Tarantini, G; Brener, Sj; Barioli, A; Gratta, A; Parodi, Guido; Rossini, R; Navarese, Ep; Niccoli, G; Frigo, Ac; Musumeci, G; Iliceto, S; Stone, G. W.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 167(3):3(2014), pp. 401-412. [10.1016/j.ahj.2013.11.013.]

Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials.

PARODI, Guido;
2014

Impact of baseline hemorrhagic risk on the benefit of bivalirudin versus unfractionated heparin in patients treated with coronary angioplasty: A meta-regression analysis of randomized trials / Tarantini, G; Brener, Sj; Barioli, A; Gratta, A; Parodi, Guido; Rossini, R; Navarese, Ep; Niccoli, G; Frigo, Ac; Musumeci, G; Iliceto, S; Stone, G. W.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 167(3):3(2014), pp. 401-412. [10.1016/j.ahj.2013.11.013.]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/182025
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 22
social impact